evolocumab
amgen
[]
#acc2023 overview of yellow-3 empaglifozocin reduces tcfa phenotype and plaque lipid burden. interesting insights will come from genetic substudies particularly in non responders 
Professor of Interventional Cardiology @KeeleUniversity. Research interests: CV Epidemiology. AE Circulation: Cardiovascular Interventions. TCTMD. EAPCI. Hiking